Mel Spigelman

Mel Spigelman is the president and chief executive of the Global Alliance for TB Drug Development (TB Alliance). He is regarded as one of the world’s leading experts in tuberculosis and TB drug development.

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum